ADMINISTRATIVE SUPPLEMENTS FOR HEALTH DISPARITIES RESEARCH

Release Date:  October 4, 2001
       
NOTICE:  NOT-DA-01-011

National Institute on Drug Abuse
 (http://www.nida.nih.gov)

PURPOSE

The National Institute on Drug Abuse (NIDA) announces the availability of 
funds to supplement existing NIDA-supported research projects to give 
researchers the opportunity (1) to recruit additional study participants, or 
(2) to expand analyses of existing samples, which already have sufficient 
representation from various racial/ethnic minority populations, in order to 
assess patterns of drug use, effects and potential adverse behavioral, social 
and health consequences, or differential treatment outcomes within and across 
racial/ethnic groups. It is expected that recruitment of additional 
participants or secondary analysis of existing data sets will allow for 
meaningful comparisons and analyses to be made between specific racial/ethnic 
groups and lead to a better understanding of the racial/ethnic disparities in 
the prevalence, incidence, pattern and consequences, of drug abuse, and in 
the effectiveness of prevention and treatment approaches. It is also expected 
that recruitment of adequate numbers of racial/ethnic minority participants 
in behavioral and/or pharmacological studies will lead to the development and 
implementation of culturally sensitive treatment approaches. Funding will be 
available through administrative supplements.  Existing grants eligible for 
supplemental support under this notice include research projects (R01, R03, 
R21, Center grants and Program projects) with at least one year of support 
remaining. Supplements may be requested for up to 2 years of support, but 
extend no longer than the parent grant, with funding beginning no later than 
September 30, 2002.  For more information refer to 
http://www.drugabuse.gov/Funding/HDispGuide.html.

INQUIRIES 

Inquiries concerning this notice are strongly encouraged.  The opportunity to 
clarify any issue or questions from potential applicants is welcome.

Direct inquiries regarding programmatic issues to:

David Shurtleff, Ph.D.
Division of Neuroscience and Behavioral
National Institute on Drug Abuse
6001 Executive Boulevard, Room 4S-4284, MSC 9555
Bethesda, MD  20892-9555
Telephone: (301) 443-1887
Email:  dshurtle@mail.nih.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer or Video files, see Help Downloading Files.